Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rigaku NEX QC EDXRF for Analysis of Sulfur in Gypsum

Published: Tuesday, January 15, 2013
Last Updated: Monday, January 14, 2013
Bookmark and Share
New NEX QC energy dispersive X-ray fluorescence spectrometer yields excellent results.

Applied Rigaku Technologies, Inc. has announced a new empirical method for the analysis of sulfur in gypsum. Gypsum is a soft sulfate mineral added to Portland cement to prevent flash setting of concrete.

Application Note #1255 demonstrates the performance of the Rigaku NEX QC energy dispersive X-ray fluorescence (EDXRF) spectrometer in the monitoring of gypsum for quality control during the cement production process.

X-ray fluorescence (XRF) spectroscopy is integral to control of the production process in modern cement plants, enabling a cement maker to produce a consistent product.

Energy dispersive X-ray fluorescence spectrometry is a routinely employed for screening and quality control, providing rapid compositional data at various stages of production.

Whether at the quarry, cement plant or industrial manufacturing site, the sulfur content of the gypsum as it is processed needs to be closely monitored to ensure the quality and proper formulations of the final products.

EDXRF analyzers are typically implemented to monitor the addition of gypsum throughout the manufacturing process.

For this method, each gypsum sample is prepared by grinding the material to dry, homogeneous powder <200 mesh (<75um particle size).

Approximately 8 grams of powder is then placed in a 32mm sample cup and packed to an even and consistent sample. Empirical calibration was developed using a set of six assayed standards with sulfur content ranging between 12-17%.

Analytical results and precision data are shown from the measurement of the low and high Sulfur content calibration standards. Detection limits were in part determined by the calibration range and analysis time.

The data confirm that the NEX QC analyzer yields excellent results for the measurement of sulfur in gypsum, without the need for helium purge. Other elements in the gypsum, including calcium, can also be measured.

The method shows how the Rigaku NEX QC analyzer, with its simple, modern touch screen interface, enables reliable and efficient measurement to meet analytical needs at the quarry or cement plant when testing gypsum and finished cement, as well as during the manufacturing of other gypsum products.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rigaku Raman Technologies Announces Rebrand to Rigaku Analytical Devices
Rigaku Analytical Devices sets benchmark in spectroscopy industry with portfolio of powerful customizable handheld and portable spectroscopic analyzers.
Friday, June 05, 2015
Rebrand for Rigaku Raman Technologies
Rigaku Raman Technologies has announced it will formally operate as Rigaku Analytical Devices.
Monday, June 01, 2015
Rigaku Announce New President & COO
Company appoints Mr. Yoichi Yokomizo as Chief Operating Officer of RAH.
Tuesday, April 07, 2015
Rigaku to Acquire Agilent’s X-Ray Diffraction Business
Company plans to combine XRD with its existing crystallography business to form a new business unit.
Wednesday, April 01, 2015
European Crystallography Meeting delegates Raise Money for Charity
Cycling enthusiasts at the 28th European Crystallography Meeting (ECM) have used the occasion to raise money for Cancer Research.
Wednesday, October 02, 2013
Rigaku and Emerald Bio Announce Strategic Alliance
Partnership to broaden customer solutions in protein crystallography.
Thursday, August 01, 2013
Analysis of Sulfur and Chlorine in Oil by Energy Dispersive X-ray Fluorescence
Monitoring the sulfur and chlorine content is critical in the production of various oils and oil products.
Wednesday, May 15, 2013
Texas State University Acquires Rigaku SCXmini Chemical Crystallography Instrument
The University has purchased the benchtop small molecule XRD crystallography instrument for Cyber-enabled for cyber-enabled teaching and research.
Thursday, January 08, 2009
Monash University Purchases Rigaku CrystalMation system for The Protein Crystallography Unit
The system is chosen in support of macromolecular crystallographic studies carried out by researchers at Monash University and their collaborative partners.
Friday, September 26, 2008
Rigaku Wins "Most Innovative New Technology" Award for CrystalMation™ and Desktop Minstrel™ UV Products
Company receives award for the Rigaku Desktop Minstrel UV system and Rigaku CrystalMation system at the ELRIG Protein Crystallography Conference.
Wednesday, April 23, 2008
Rigaku Sponsors Carl Brändén Award
The 2007 Carl Brändén Award was presented to Prof. Lubert Stryer for his exceptional contributions to education in biochemistry and molecular biology.
Monday, June 04, 2007
Rigaku Leads in Protein Structure Productivity Based on Analysis of Protein Data Bank Submissions
Data show that structures solved with Rigaku home laboratory X-ray generators comprised 17% of all submitted structures for 2005.
Wednesday, March 07, 2007
Rigaku Launches new Corporate Website
The website integrates all Rigaku products and business units with a common look and feel for an enhanced Internet browsing experience.
Wednesday, November 01, 2006
Rigaku Announces Reorganization
Rigaku Americas Corporation became the operating entity in charge of North America.
Tuesday, October 18, 2005
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Real-Time Imaging of Embryo Development Could Pave the Way
Researchers at IMCB have developed advanced microscopy technologies to monitor embryo development for more effective human reproduction therapies.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!